GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indivior PLC (NAS:INDV) » Definitions » Research & Development

Indivior (Indivior) Research & Development : $107 Mil (TTM As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Indivior Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Indivior's Research & Development for the three months ended in Mar. 2024 was $28 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was $107 Mil.

Indivior Research & Development Historical Data

The historical data trend for Indivior's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indivior Research & Development Chart

Indivior Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 53.00 40.00 52.00 72.00 106.00

Indivior Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.00 32.00 18.00 29.00 28.00

Indivior Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $107 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indivior  (NAS:INDV) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Indivior Research & Development Related Terms

Thank you for viewing the detailed overview of Indivior's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Indivior (Indivior) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indivior PLC (NAS:INDV) » Definitions » Research & Development
Comparable Companies
LSE:HCM LSE:BMK LSE:APH LSE:HIK LSE:ANCR LSE:EAH LSE:AGY LSE:CEL LSE:STX LSE:VLG ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
INDVl:UK INDV:UK 2IVB:Germany
Address
234 Bath Road, Slough, Berkshire, GBR, SL1 4EE
Website
http://www.indivior.com
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by the rest of the world. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.